Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders

JAMA. 2017 Sep 5;318(9):793-794. doi: 10.1001/jama.2017.10697.
No abstract available

MeSH terms

  • Advisory Committees
  • Anesthetics, Dissociative / adverse effects
  • Anesthetics, Dissociative / therapeutic use*
  • Chronic Disease / drug therapy
  • Humans
  • Ketamine / adverse effects
  • Ketamine / therapeutic use*
  • Mood Disorders / drug therapy*
  • Off-Label Use*

Substances

  • Anesthetics, Dissociative
  • Ketamine